| Drug Name | (Jardiance®( Empagliflozin |
|---|---|
| Drug Class |
Anti-diabetic
|
| Risk minimization type |
Patient Card
|
| Specialty (Theraputic area) |
Endocrine
|
| Risk |
Risk of diabetic ketoacidosis |
| Patient card |
|
| safety communication |
|
| Dear Healthcare provider letter DHPC |
|